| __timestamp | Amgen Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 20622000 |
| Thursday, January 1, 2015 | 4846000000 | 33837000 |
| Friday, January 1, 2016 | 5062000000 | 35979000 |
| Sunday, January 1, 2017 | 4870000000 | 25003000 |
| Monday, January 1, 2018 | 5332000000 | 19269000 |
| Tuesday, January 1, 2019 | 5150000000 | 15426000 |
| Wednesday, January 1, 2020 | 5730000000 | 14456000 |
| Friday, January 1, 2021 | 5368000000 | 20488000 |
| Saturday, January 1, 2022 | 5414000000 | 27195000 |
| Sunday, January 1, 2023 | 6179000000 | 30914000 |
| Monday, January 1, 2024 | 7096000000 |
Infusing magic into the data realm
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Amgen Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches. From 2014 to 2023, Amgen's SG&A expenses have shown a steady upward trajectory, peaking at approximately 6.2 billion in 2023, a 31% increase from 2014. In contrast, Celldex's spending has been more volatile, with a peak in 2016 and a subsequent decline, only to rise again to about 31 million in 2023. This represents a 50% increase from their lowest point in 2020. These patterns reflect broader strategic priorities, with Amgen focusing on sustained growth and Celldex navigating a more fluctuating path. Understanding these trends offers valuable insights into each company's operational focus and market positioning.
Selling, General, and Administrative Costs: Amgen Inc. vs Sanofi
Operational Costs Compared: SG&A Analysis of Amgen Inc. and BioMarin Pharmaceutical Inc.
Amgen Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing Revenue Performance: Amgen Inc. or Celldex Therapeutics, Inc.?
Who Optimizes SG&A Costs Better? Amgen Inc. or Galapagos NV
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Celldex Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
MannKind Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. or Evotec SE: Who Manages SG&A Costs Better?